Filing Details
- Accession Number:
- 0000899243-21-026817
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-30 18:59:34
- Reporting Period:
- 2021-06-29
- Accepted Time:
- 2021-06-30 18:59:34
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1796129 | Vincerx Pharma Inc. | VINC | Pharmaceutical Preparations (2834) | 833197402 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1832562 | A. Alexander Seelenberger | 260 Sheridan Avenue, Suite 400 Palo Alto CA 94306 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-06-29 | 7,950 | $12.61 | 7,950 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- Represents a weighted average purchase price. Actual purchase prices ranged from $12.56 to $12.69 per share. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares purchased within the range indicated.